Swapan Bhattacharya is the Managing Director of our company. Mr. Bhattacharya is responsible for the executive leadership and overall management of the company. He has been associated with the TCG group since 1995 and has spear headed the group’s investments in India and its foray into life sciences from 1998. He has over 30 years of experience in national and international organizations. Prior to joining us, he has held positions with Paine Webber Inc. as Senior Vice President; and with the US Nuclear Regulatory Commission. In January 2009 has been awarded ‘Udyog Rattan’ Award by Institute of Economic Studies, India for his outstanding contribution in India’s industrial development. He is also the Ex Co-Chairman of the biotechnology committee of Federation of Indian Chambers of Commerce and Industry ("FICCI") and holds various committee positions in US India Business Council, CII and AMCHAM. He holds a bachelor’s degree in technology from the Indian Institute of Technology, Kharagpur, a master of sciences from the Virginia Polytechnic Institute and State University, U.S.A and a degree in Master of Business Administration from Kellogg School of Management, Northwestern University, U.S.A.
Vice President - Chemistry
Dr. Saha is a part of the core team responsible for the growth of the company. He has been with TCG Lifesciences since 2001. Prior to joining TCG Lifesciences he worked with the Florida Institute of Technology, USA as a Research Scientist. He was also a visiting professor at Osaka University, Japan. He has published 17 papers in international journals. Dr. Saha is a PhD from the Indian Association for the Cultivation of Science, Kolkata, India.
Vice President - Finance
Mr. Pandya is currently responsible for the financial management of the company. He has been associated with TCG Lifesciences since 2001. He has over 20+ years of experience in finance. Prior to joining the company, he was employed with DSP Merrill Lynch, ITC Classic Finance, Institute of Molecular Medicine and Chatterjee Management Services Private Limited. He holds a bachelor's degree in chemical engineering from the Indian Institute of Technology, Kharagpur and Post Graduate Diploma in Management from Indian Institute of Management, Bangalore, India.
Vice President - Chemistry
Dr. Roy is one of the key members responsible for the growth of the company. He has been with the company since 2002. He has more than 16 years of Industrial experience. He is a specialist in new process development and process optimization. Dr. Roy has several publications to his credit and holds seven European patents. He has played a key role in conceptualizing and designing of the Kilo Laboratory. After a brief stint with AVRA Laboratories, he joined University of Kansas for his post doctoral work under Dr. Gunda I George from 1999 to 2002. Dr. Roy did his PhD from Indian Institute of Chemical Technology, Hyderabad, India.
Associate Vice President - Chemistry
Dr. Dutta is a key member of the scientific leadership team at TCG Lifesciences. He is an accomplished scientific professional with 13 years of industrial & 16 years of research experience and expertise in Organic, Bio-Organic, Medicinal and Combinatorial Chemistry. He has a strong track record of delivering preclinical leads for clinical development in both integrated drug discovery programs as well as CRO services. He has re-joined the company in 2015, after a year’s tenure in GVK Biosciences, where he played scientific and strategic leadership role. Prior to that, Dr. Dutta has a long association of more than ten years with TCG Lifesciences, when he successfully managed some of the key collaborations and built strong client relationships with high quality delivery and scientific excellence. He has a number of publications and presentations published in prestigious peer-reviewed journals. He also has several awards and honors to his credit. Dr. Dutta has post-doctoral research experience from The Scripps Research Institute, La Jolla, CA, USA. He has earned his Ph.D. from Indian Institute of Chemical Technology, Hyderabad, India and his masters in Organic Chemistry from Jadavpur University, India.
Vice President - Analytical Chemistry
Dr. Roychowdhury is a part of the core team responsible for the growth of the company. He has been with the company since 2001. His area of expertise includes method development and validation of new chemical entities, and impurity profiling and characterization of novel molecules. Prior to joining the company he worked with Ranbaxy Research Laboratories, Lupin Pharmaceuticals and Hindustan Aluminum Corporation. Dr. Roychowdhury is a PhD from Banaras Hindu University in Organic Chemistry, India.
Associate Vice President - Commercial
Mr. Dasgupta is responsible for managing legal and environmental compliances, procurement, sourcing, logistics and export & import procedures. Mr. Dasgupta has been associated with the company since inception. He has over 27 years experience in chemical industry and prior to joining TCG Lifesciences he has worked with NALCO for 11 years. Mr. Dasgupta is a certified Chartered Accountant.
Associate Vice President - IT
Mr. Basu joined TCGLS in 2002 and is responsible for all IT integration inclusive hardware and software solutions at TCGLS. Prior to joining TCGLS, he worked with TCG Software, NIIT & CMC Ltd. Mr. Basu did his post graduation in computer science & technology from Indian Institute of Technology, Kanpur, India in the year 1999.
Associate Vice President - Custom Synthesis and Medicinal Chemistry
Dr. Venkatesan is a part of core scientific team representing our company in the USA. He joined our company in the year 2014. He has twenty three years of research experience in Discovery Medicinal Chemistry with proven success in multiple therapeutic areas such as ADC, Oncology, Immunology/Inflammation, Cardiovascular diseases and Infectious diseases. Prior to joining us, he was working with Endo Pharmaceuticals as Associate Director. His industry experience includes Lederle Labs, Wyeth and Pfizer Research. Dr. Venkatesan has contributed to various clinical candidates as an inventor. He has 52 publications in peer-reviewed journals, 55 patents and 11 additional U.S. patents applications in various phases of issuance; along with many awards and honors to his credit. Dr. Venkatesan has done his Post-Doctoral from Columbia University, USA, Ph.D. in Organic Chemistry, New York University, USA and M.Sc. in Organic Chemistry from University of Bombay, India.
Director - Biology
Dr. Chattopadhyay is one of the key members responsible for initiation and growth of the Biology division of the company. He has been with TCG Lifesciences since inception of Biology division of the company in 2003. He has more than 15 years of Industrial experience and 30 publications in peer reviewed journals. Initiating his postdoctoral career in RIKEN, Wako-shi, Japan as postdoctoral researcher, he joined National Institutes of Health, MD, USA as a Fogarty International fellow and was a Post Doctoral Research Associate at the University of Rochester Medical Center, NY, before joining the company in 2003. Dr. Chattopadhyay did his Ph.D. in Biophysics and Molecular Biology from University of Calcutta, India and he was a Calcutta University topper in his undergrads.
Director - Business Development
Mr. Hirose is currently responsible for business development in Japan. He joined the company in the year 2008. Mr. Hirose is equipped with 24 vast years of experience in the pharma industry. He held various positions at Okahata Co., Ltd, Seika Sangyo Co., Ltd, Itochu Chemical Frontier Corp, etc. Mr. Hirose has done his B.S. in Chemistry from University of Tokushima in 1991.
Director - Business Development
Dr. Sanjoy Kumar Mahanty is a part of core Business Development team in the USA. He joined TCG Lifesciences in the year 2015. Dr. Mahanty has 22 years experience in academia and business development in the Biotech/Pharmaceutical industry. Prior to joining the company, he worked with Regado Biosciences Inc. as Executive Director, Biology, a Senior Scientist, Pharmacology at Inspire Pharmaceuticals, and Manager, Cell Biology at Paradigm Genetics, Inc. Dr. Mahanty has an extensive experience in drug discovery & development in the areas of scientific research, management, business, financing, contract negotiation, new target identification, and preclinical & clinical testing. He has 18 co-authored peer reviewed publications, one book chapter, and 10 patents to his credit. Dr. Mahanty has Post-Doctoral Research Experience from Harvard Medical School, Boston, and University of North Carolina, Chapel Hill, USA. He holds a Ph.D. degree in Biochemistry and M.Sc. in Lifesciences from Jawaharlal Nehru University, New Delhi, India.
Associate Vice President-Chemistry
Dr. Majumdar is one of the key members of scientific leadership team responsible for the growth of the company. He has been associated with the company since 2001. He has 17 years of industry experience and a strong track record in Contract Research Services in the areas of medicinal chemistry, process research and parallel medicinal chemistry. Dr. Majumdar has been managing multiple key collaborations for the past 13-15 years, he has built strong relationships with his customers through his scientific excellence and managerial skills. His recent interest is in macrocycle synthesis (solution phase) of 12-20 membered ring sizes. His team has delivered >500 macrocycle building blocks in gram scale involving diversified parts of organic molecules such as aromatic, heteroaromatics, alicyclic, alkyl and amino acids and many classical organic synthesis involving C-C, C-O and C-N bond forming reactions. Dr. Majumdar was top ranked student in M.Sc from University of North Bengal, qualified at the national level entrance examination before joining his PhD program in Indian Institute of Chemical Technology, Hyderabad, India. He has multiple post-doctoral research experiences from Indian Institute of Science, Bangalore; National Tsing Hua University, Taiwan and UT Southwestern Medical Center, Dallas, TX, USA before he joined TCGLS. He has a number of patents and articles published in prestigious peer-reviewed journals.
Associate Vice President- Polymer and Specialty Chemistry
Soumen Sensarma, head of polymer and specialty chemicals of TCG Lifesciences (“TCGLS”), joined the company in June 2017. He has more than 20 years of Industrial experience in the field of polymer, materials and specialty chemicals. He is a specialist in developing new catalyst for polyolefin synthesis and process development. Also, he is responsible for developing new materials exploiting organic chemistry and nanotechnology as well as innovative applications for future needs. Furthermore, he is looking for sustainable solutions for the benefit of the society, including research on waste to value added products.
Prior to joining TCGLS, Soumen spent a decade at the Tata Chemicals Innovation Center in Pune, India. He received the prestigious Tata Innovista and Titan innovation awards there. Prior to that, he has worked at DSM research, University of Ottawa and GE, Bangalore.
Soumen did his PhD in polymer chemistry at National Chemicals Laboratory, Pune, India under Prof. S. Sivaram. He holds more than 20 patents both in India and internationally. He is the key architect for creating innovative products and solutions for Haldia Petrochemicals and has already filed a few patent applications
Vice President, Business Development
Dr Brian Moloney is resident in San Diego, California, and covers Business Development for TCG Lifesciences for the US West Coast, and Europe. Brian has almost 30 years experience in the Agrochemical, Biotech/Pharma, and CRO industries, in both Operations and in Business Development. Prior to joining TCGLS in April 2018, Brian was with WuXi AppTec, eMolecules, BioDuro, Evotec, and AgrEvo/Sanofi. Brian was a pioneer in the combinatorial chemistry and automation fields, and has authored many scientific papers and patents. A fungicide designed and synthesized under Brian's direction, has been commercialized. Brian obtained his Chemistry BSc at Leicester University, England, his PhD from Cardiff University, Wales, and did his Post-Doctoral studies at Stanford University, California.